Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2025-12-25 @ 8:18 PM
Study NCT ID:
NCT00267969
Status:
COMPLETED
Last Update Posted:
2013-06-17
First Post:
2005-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
Sponsor:
Centocor Research & Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2006-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-20
First Submit QC Date:
None
Study First Post Date:
2005-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-10-23
Results First Submit QC Date:
None
Results First Post Date:
2012-08-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-10
Last Update Post Date:
2013-06-17
Last Update Post Date Type:
ESTIMATED